Volpara’s Board meets in person at RSNA to do a complete strategic review of the company, with a view to the FY2020 budget and beyond. This year’s Board meeting was notable for the positive outlook for the company and the sheer number of opportunities ahead of us.
A highlight for Volpara at RSNA was the launch of the VolparaLive! system. Below is a picture of the interface. The aim is to tell the technologist within seconds about the quality of the exam and to help her consider whether the quality is good enough before the woman goes home:
“We had a great reaction from the visitors who saw the VolparaLive! system at the Volpara booth, and we believe the product is going to do well on the market,” Volpara Chief Executive Dr Ralph Highnam said. “This product complements the VolparaDensity clinical application and VolparaEnterprise software, so will add valuable ARPU for us, as well as attract new customers.”
Volpara hosted a distinguished speaker series at the RSNA meeting which included Prof Jack Cuzick, Director, Wolfson Institute of Preventative Medicine; JoAnn Pushkin, Executive Director, DenseBreast-Info.org; Prof Sir Mike Brady, Professor of Oncological Imaging, University of Oxford; and Amy Chatten, Executive Director, Mammography Educators, LLC; and a live TweetChat with the Radiology Chicks. Pictures below: